Ophthalmology provider Newmedica is calling for greater transparency by all providers over glaucoma waiting lists to tackle a ‘postcode lottery’ facing patients. Coinciding with Glaucoma Awareness Week (30 June – 6 July), Newmedica, which provides NHS and private ophthalmology services,...
The National Institute for Health and Care Excellence (NICE) has recently approved Vabysmo▼(faricimab) for treating adults with visual impairment due to macular oedema secondary to branch and central retinal vein occlusion (BRVO and CRVO). The NICE approval of Vabysmo was...
New data from sight loss charity RNIB reveals that 8730 people in Scotland will begin living with sight loss in the next 12 months alone, and that the total number of people affected is set to grow by nearly 21%...
Newmedica has welcomed the publication of NHS England’s Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services, recognising it as an important step toward improving consistency and outcomes for patients across England. The guidance’s emphasis on patient...
David Shahnazaryan, Consultant Ophthalmologist, London, UK and Radhika Rampat, Consultant Ophthalmologist, London, UK, report from the AECOS Symposium in Antwerp, Belgium (June 10-12).
The Lord Provost of Edinburgh, Councillor Robert Aldridge, has praised Sight Scotland Veterans for the ‘incredible support’ it provides to veterans living with sight loss during a recent visit to the charity’s Linburn Centre in West Lothian. The Lord Provost,...
Surgitrac Instruments proudly participated in the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) this September, celebrating 30 years of heritage. The congress was the ideal opportunity to showcase our expertise in manufacturing and supplying high-quality...
The Retina UK Annual Conference 2025 took place at the Holiday Inn London in London, UK, on 20 September and was hosted both in-person and online. The event included expert speakers, healthcare professionals, and patients with lived experience with retinal...
The author examines the current visual standards required by drivers and asks whether more needs to be done to make roads safer. Are the public adequately protected by the current system of visual standards required by drivers? In a survey...
In this prospective study the authors evaluate the effect of intravitreal aflibercept injections in the treatment of naive type 3 neovascularisation using a fixed treatment regime. Fourteen eyes of 14 patients were studied. All patients were treated with intravitreal 2.0...